Tenaya Therapeutics (TNYA) Non-Current Assets (2020 - 2026)

Tenaya Therapeutics has reported Non-Current Assets for 7 years, with the latest figure at $38.5 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Assets fell 22.15% year-over-year to $38.5 million; the trailing twelve-month figure through Mar 2026 stood at $169.9 million (down 21.16% YoY), and the FY2025 full-year result was $41.3 million, down 21.36% from the prior year.
• Non-Current Assets for Q1 2026 stood at $38.5 million, down from $41.3 million in the prior quarter.
• The five-year high for Non-Current Assets was $90.7 million in Q1 2023, with the low at $38.5 million in Q1 2026.
• Average Non-Current Assets over 5 years is $60.7 million, with a median of $58.2 million recorded in 2024.
• Year-over-year, Non-Current Assets surged 60.82% in 2022 and slumped 38.05% in 2024.
• Tracing TNYA's Non-Current Assets over 5 years: stood at $85.2 million in 2022, then tumbled by 30.82% to $58.9 million in 2023, then dropped by 10.81% to $52.6 million in 2024, then slipped by 21.36% to $41.3 million in 2025, then declined by 6.84% to $38.5 million in 2026.
• The last three Non-Current Assets figures came in at $38.5 million (Q1 2026), $41.3 million (Q4 2025), and $43.7 million (Q3 2025), per Business Quant data.

Peer Comparison